Cargando…
Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species
A major challenge in developing vaccines for emerging pathogens is their continued evolution and ability to escape human immunity. Therefore, an important goal of vaccine research is to advance vaccine candidates with sufficient breadth to respond to new outbreaks of previously undetected viruses. E...
Autores principales: | Hensley, Lisa E., Mulangu, Sabue, Asiedu, Clement, Johnson, Joshua, Honko, Anna N., Stanley, Daphne, Fabozzi, Giulia, Nichol, Stuart T., Ksiazek, Thomas G., Rollin, Pierre E., Wahl-Jensen, Victoria, Bailey, Michael, Jahrling, Peter B., Roederer, Mario, Koup, Richard A., Sullivan, Nancy J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873919/ https://www.ncbi.nlm.nih.gov/pubmed/20502688 http://dx.doi.org/10.1371/journal.ppat.1000904 |
Ejemplares similares
-
A New Approach for Monitoring Ebolavirus in Wild Great Apes
por: Reed, Patricia E., et al.
Publicado: (2014) -
Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial
por: Sarwar, Uzma N., et al.
Publicado: (2015) -
Transcriptional Correlates of Disease Outcome in Anticoagulant-Treated Non-Human Primates Infected with Ebolavirus
por: Garamszegi, Sara, et al.
Publicado: (2014) -
843. The PALM Consortium: A Multicenter, Multioutbreak Randomized Controlled Trial of Ebola Virus Disease Therapeutics
por: Mulangu, Sabue
Publicado: (2019) -
Virus kinetics and biochemical derangements among children with Ebolavirus disease
por: Kjaldgaard, Lindsey, et al.
Publicado: (2022)